Evidence map›Paper›PMID 29312602›Full record

ArticleOncotarget2017

Tanshinone IIA inhibits angiogenesis in human endothelial progenitor cells

Hsiang-Ping Lee, Yueh-Ching Liu, Po-Chun Chen, Huai-Ching Tai, Te-Mao Li, Yi-Chin Fong, Chih-Shiang Chang, Min-Huan Wu, Li-Pin Chiu, Chia-Jung Wang and 4 more

Open access · diamondAbstract read
In one paragraph

Article in Oncotarget, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 26 papers.

0numbers the graph read from it
0cells of the map it votes in
26citing papers in PubMed
5.1field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

26 citing papers in PubMed, 38 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Review
  5. Article
  6. Article
  7. Review
  8. Review
  9. Article
  10. Review
  11. Review
  12. Frontiers in pharmacology · 2022
    Review
  13. Review
  14. Article
  15. Review
  16. Review
  17. Article
  18. An overview of the anti-cancer actions of Tanshinones, derived fromExploration of targeted anti-tumor therapy · 2020
    Review
  19. Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 8 institutions in 1 country.

Hsiang-Ping LeeGraduate Institute of Chinese Medicine, China Medical University, Taichung, Taiwan.
Yueh-Ching LiuDepartment of Orthopaedics, Mackay Memorial Hospital, Taipei, Taiwan.
Po-Chun ChenGraduate Institute of Biomedical Science, China Medical University, Taichung, Taiwan.
Huai-Ching TaiSchool of Medicine, Fu-Jen Catholic University, New Taipei City, Taiwan.
Te-Mao LiGraduate Institute of Chinese Medicine, China Medical University, Taichung, Taiwan.
Yi-Chin FongDepartment of Sports Medicine, College of Health Care, China Medical University, Taichung, Taiwan.
Chih-Shiang ChangGraduate Institute of Pharmaceutical Chemistry, China Medical University, Taichung, Taiwan.
Min-Huan WuPhysical Education Office, Tunghai University, Taichung, Taiwan.
Li-Pin ChiuDepartment of Nursing, Taipei City Hospital, Taipei, Taiwan.
Chia-Jung WangDepartment of Medicine, Mackay Medical College, New Taipei City, Taiwan.
Yi-Hsuan ChenDepartment of Medicine, Mackay Medical College, New Taipei City, Taiwan.
Yih-Jer WuDepartment of Medicine, Mackay Medical College, New Taipei City, Taiwan.
Chih-Hsin TangGraduate Institute of Biomedical Science, China Medical University, Taichung, Taiwan.
Shih-Wei WangDepartment of Medicine, Mackay Medical College, New Taipei City, Taiwan.
China Medical University · TWMackay Medical College · TWAsia University · TWChina Medical University Beigang Hospital · TWFu Jen Catholic University · TWMackay Memorial Hospital · TWTunghai University · TWUniversity of Taipei · TW

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Accumulating evidence reports that bone marrow-derived endothelial progenitor cells (EPCs) regulate angiogenesis, postnatal neovascularization and tumor metastasis. It has been suggested that understanding the molecular targets and pharmacological functions of natural products is important for novel drug discovery. Tanshinone IIA is a major diterpene quinone compound isolated from Danshen (

Indexed as

angiogenesisendothelial progenitor cellstanshinone IIAVEGF-A

Identifiers

PMID29312602
PMCPMC5752515
OpenAlexW2768504809

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.